<DOC>
	<DOCNO>NCT00057278</DOCNO>
	<brief_summary>This study ass safety effectiveness drug gabapentin reduce pain associate primary fibromyalgia .</brief_summary>
	<brief_title>Gabapentin Fibromyalgia Trial ( GIFT )</brief_title>
	<detailed_description>Fibromyalgia , chronic musculoskeletal pain disorder unknown etiology , characterize widespread musculoskeletal pain , fatigue , multiple tender point ; disease affect 3 6 million Americans . A person consider fibromyalgia widespread pain combination tenderness least 11 18 specific tender point site . Treatment fibromyalgia require comprehensive approach include aerobic exercise , heat massage , antidepressant medication , relaxation . Gabapentin , medication use treat seizure , show work pain transmission pathway may relieve pain associate fibromyalgia . This study ass efficacy gabapentin reduce pain severity fibromyalgia measure average pain item Brief Pain Inventory ( BPI ) score . Patients randomize receive gabapentin placebo . The gabapentin dose titrate persist symptom tolerate first 6 week study , reach final dos 1800 mg/day 2400 mg/day . Patients continue final dose remain 6 week study . Following completion 12 week treatment phase , patient taper medication 1 week . The effectiveness gabapentin assess use BPI . The BPI self-administered questionnaire measure severity pain interference pain function past 24 hour . Other assessment include total Fibromyalgia Impact Questionnaire ( FIQ ) score ; six 11-point Likert-type scale FIQ measure pain , fatigue , morning tiredness , stiffness , anxiety , depression ; mean tender point pain threshold ; Clinical Global Impression Severity ( CGI-Severity ) ; Patient Global Impression Improvement ( PGI-Improvement ) ; Short-form McGill Pain Questionnaire ( SF-MPQ ) ; Medical Outcomes Study Short Form-36 ( SF-36 ) ; Montgomery Asberg Depression Rating Scale ( MADRS ) ; Medical Outcomes Sleep Scale ( MOS-Sleep ) .</detailed_description>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Primary fibromyalgia define American College Rheumatology ( ACR ) Score great 4 average pain item BPI screen Ability understand cooperate study procedure Acceptable method contraception Unwillingness inability provide write informed consent . Lifetime history psychosis , hypomania mania , epilepsy , dementia History seizure status epilepticus DSMIV diagnosis alcohol substance dependence exception nicotine dependence within 6 month prior screen visit A positive urine drug screen substance abuse exclude medication . ( NOTE : If participant positive drug screen Visit 1 exclude medication may adequate washout period , retest may perform prior Visit 2 . If retest positive , participant exclude . ) Serious suicide risk Treatment refractory opinion study official Pregnant breastfeeding Clinically unstable medical psychiatric condition could interfere absorption , metabolism , excretion , safety gabapentin interfere assessment disease severity Thyroidstimulating hormone ( TSH ) concentration outside range 0.308.0 UlU/mL . ( NOTE : Participants stable dose thyroid supplementation least past 3 month , medically appropriate TSH value , clinically euthyroid may participate study . ) Any screen laboratory assay outside local laboratory ' normal range 20 % deem clinically significant abnormality investigator , exception liver function test ( AST , ALT , alkaline phosphatase ) must within 1.5 X upper limit normal Inability exclude traumatic injury , regional structural rheumatic disease , infectious arthropathy etiology relevant symptom would interfere interpretation outcome measure ( e.g. , osteoarthritis , bursitis , tendonitis ) History autoimmune disease inflammatory arthritis , systemic lupus erythematosis ( SLE ) rheumatoid arthritis ( RA ) . An abnormal Westergren erythrocyte sedimentation rate ( e.g. , ESR &gt; 40 mm/min ) An abnormal antinuclear antibody ( ANA &gt; 1:160 ) rheumatoid factor ( RF &gt; 15 IU/ml ) Treatment monoamine oxidase inhibitor , tricyclic , SSRI antidepressant ( exception fluoxetine ) , lithium within 2 week prior begin study medication Treatment fluoxetine within 30 day prior begin study medication Treatment analgesic medication ( exception acetaminophen overthecounter NSAIDs ) within 1 week prior begin study medication Treatment exclude medication discontinue screen visit ( see Table 2 list exclude medication ) Previous treatment gabapentin Previous treatment pregabalin Treatment investigational medication within 30 day prior screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Gabapentin</keyword>
</DOC>